Fig. 3From: Early prediction of pathologic response to neoadjuvant treatment of breast cancer: use of a cell-loss metric based on serum thymidine kinase 1 and tumour volumePercentage of pathological complete response in the breast after six cycles of chemotherapy among 104 women, grouped into quartiles according to the cell-loss metric obtained 48 h after the 2nd treatment cycleBack to article page